Saturday, March 21, 2026

Latest

Green Thumb: Analyst Consensus Estimates For Q3 2021

Green Thumb Industries (CSE: GTII) announced that they will be reporting their third quarter financials after the markets close on November 10th.

Analysts have a consensus C$59.06 12-month price target on the company, via a total of 16 analysts, with 4 analysts having strong buy ratings, and the other 12 having buy ratings on the company. The street high comes from Stifel-GMP with an C$80 price target, and the lowest target comes from Roth Capital Partners with a C$40 price target.

15 analysts have revenue estimates for the third quarter. The mean between all 15 is US$233.33 million; this number has been revised slightly upwards from US$221.54 million at the start of May. The street high is US$250.60 million while the lowest sits at US$222.27 million.

Six analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 55.32%, with this number being flat at the start of May. Street high is 57% estimate and the lowest sits at 54%.

Onto EBITDA estimates, there are currently 14 analysts who have third-quarter EBITDA estimates. The mean is currently US$82.54 million, with this number being basically flat since the start of May. Street high sits at US$88.70 million EBITDA and the lowest being a US$78.23 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The $30,000 Gold Case Just Got Stronger | Simon Marcotte

Why Silver’s Move Is ‘Scary’ to Some Miners | Frank Basa

Are Commodities Entering a Generational Cycle? | Terry Lynch

Recommended

CBS News Cuts Staff and Shuts Radio Network in Early Bari Weiss Era

Steadright Closes Out Financing, Raising $1.6 Million For Moroccan Strategy

Related News

Green Thumb: Canaccord Raises Price Target To $52 Following Q4 Results

On March 17th, Green Thumb Industries (CSE: GTII) reported their fourth quarter and year end...

Saturday, March 20, 2021, 02:41:00 PM

CloudMD: Canaccord Reiterates $3.00 Price Target After Q3 Results

On November 29th, CloudMD Software & Services Inc. (TSXV: DOC) announced its third quarter financial...

Wednesday, December 1, 2021, 03:36:00 PM

Snowflake: Canaccord Drops Price Target From $360 to $210

Last week, Snowflake (NYSE: SNOW) reported its fourth-quarter fiscal 2022 financial results. The company saw...

Monday, March 7, 2022, 12:23:00 PM

Aurora Cannabis: Canaccord Anticipates Q2 Revenues Of $69.5 Million

On Thursday, February 11th, Aurora Cannabis (TSX: ACB) (NYSE: ACB) is scheduled to release their...

Tuesday, February 9, 2021, 04:01:00 PM

Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50

Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm...

Thursday, February 11, 2021, 04:07:00 PM